Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Akela Pharma Inc. AKLPF

"Akela Pharma Inc is engaged in providing contract services comprised of pharmaceutical formulation research and development, pre-clinical, clinical and commercial drug manufacturing, product development and patent litigation support."


GREY:AKLPF - Post by User

Bullboard Posts
Post by PxPx007on Nov 12, 2007 7:25pm
142 Views
Post# 13795800

Lack of interest from investors ?

Lack of interest from investors ?First, i listened to the conference call on the results. What amazed me if that no analyst stood up to ask questions, which is quite rare. Also, the difficulties related to the US IPO (cuts to 2-3M from 5M shares initially related) is another thing that confirms a certain lack of interest from the investment community. Perhaps, this is the direct cause of the US liquidity crisis and the recent downturn in the US economy. Investors might be afraid to invest in venture capital as the economy shows signs of weaknesses. Hope this does not affect the capability of AKL to finance his trials. I would have prefer a full dilution of 5M shares than risking further liquidity problems. See ya guys !
Bullboard Posts